{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:41:34Z","timestamp":1793256094789,"version":"4.5.0"},"reference-count":219,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NSF","award":["2047572 and 2052363"],"award-info":[{"award-number":["2047572 and 2052363"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05286-w","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T06:00:26Z","timestamp":1740808826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Assessing fitness costs in malaria parasites: a comprehensive review and implications for drug resistance management"],"prefix":"10.1186","volume":"24","author":[{"given":"Xyonane","family":"Segovia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavya","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Serrato-Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvie","family":"Huijben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"key":"5286_CR1","unstructured":"WHO. World malaria report 2024. Geneva, World Health Organization, 2024. Available from: https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2024."},{"key":"5286_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057689","volume":"8","author":"MP Kyaw","year":"2013","unstructured":"Kyaw MP, Nyunt MH, Chit K, Aye MM, Aye KH, Aye MM, et al. Reduced susceptibility of Plasmodium falciparum to artesunate in Southern Myanmar. PLoS ONE. 2013;8: e57689.","journal-title":"PLoS ONE"},{"key":"5286_CR3","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMc0805011","volume":"359","author":"H Noedl","year":"2008","unstructured":"Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, et al. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359:2619\u201320.","journal-title":"N Engl J Med"},{"key":"5286_CR4","doi-asserted-by":"publisher","first-page":"e02141","DOI":"10.1128\/AAC.02141-17","volume":"62","author":"T Kobasa","year":"2018","unstructured":"Kobasa T, Talundzic E, Sug-aram R, Boondat P, Goldman IF, Lucchi NW, et al. Emergence and spread of kelch13 mutations associated with artemisinin resistance in Plasmodium falciparum parasites in 12 Thai Provinces from 2007 to 2016. Antimicrob Agents Chemother. 2018;62:e02141-e2217.","journal-title":"Antimicrob Agents Chemother"},{"key":"5286_CR5","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa2211803","volume":"389","author":"MD Conrad","year":"2023","unstructured":"Conrad MD, Asua V, Garg S, Giesbrecht D, Niar\u00e9 K, Smith S, et al. Evolution of partial resistance to artemisinins in malaria parasites in Uganda. N Engl J Med. 2023;389:722\u201332.","journal-title":"N Engl J Med"},{"key":"5286_CR6","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala B, Fukuda N, Ikeda M, Katuro OT, Tachibana SI, Yamauchi M, et al. Evidence of artemisinin-resistant malaria in Africa. N Engl J Med. 2021;385:1163\u201371.","journal-title":"N Engl J Med"},{"key":"5286_CR7","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41591-021-01365-y","volume":"27","author":"A Uwimana","year":"2020","unstructured":"Uwimana A, Legrand E, Stokes BH, Ndikumana JLM, Warsame M, Umulisa N, et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat Med. 2020;27:1113\u20135.","journal-title":"Nat Med"},{"key":"5286_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01659-23","volume":"68","author":"P Awor","year":"2024","unstructured":"Awor P, Copp\u00e9e R, Khim N, Rondepierre L, Roesch C, Khean C, et al. Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda. Antimicrob Agents Chemother. 2024;68: e0165923.","journal-title":"Antimicrob Agents Chemother"},{"key":"5286_CR9","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1093\/infdis\/jiab352","volume":"225","author":"J Straimer","year":"2022","unstructured":"Straimer J, Gandhi P, Renner KC, Schmitt EK. High prevalence of Plasmodium falciparum K13 mutations in Rwanda is associated with slow parasite clearance after treatment with artemether-lumefantrine. J Infect Dis. 2022;225:1411\u20134.","journal-title":"J Infect Dis"},{"key":"5286_CR10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/1475-2875-11-292","volume":"11","author":"XC Ding","year":"2012","unstructured":"Ding XC, Ubben D, Wells TN. A framework for assessing the risk of resistance for anti-malarials in development. Malar J. 2012;11:292.","journal-title":"Malar J"},{"key":"5286_CR11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/emph\/eoy016","volume":"2018","author":"S Huijben","year":"2018","unstructured":"Huijben S, Chan BHK, Nelson WA, Read AF. The impact of within-host ecology on the fitness of a drug-resistant parasite. Evol Med Public Health. 2018;2018:127\u201337.","journal-title":"Evol Med Public Health"},{"key":"5286_CR12","first-page":"10","volume":"30","author":"SK Dhingra","year":"2019","unstructured":"Dhingra SK, Gabryszewski SJ, Small-Saunders JL, Yeo T, Henrich PP, Mok S, et al. Global spread of mutant pfcrt and its pleiotropic impact on Plasmodium falciparum multidrug resistance and fitness. MBio. 2019;30:10.","journal-title":"MBio"},{"key":"5286_CR13","doi-asserted-by":"publisher","first-page":"e51015","DOI":"10.7554\/eLife.51015","volume":"9","author":"LC Mathieu","year":"2020","unstructured":"Mathieu LC, Cox H, Early AM, Mok S, Lazrek Y, Paquet JC, et al. Local emergence in Amazonia of Plasmodium falciparum k13 C580Y mutants associated with in vitro artemisinin resistance. Elife. 2020;9:e51015.","journal-title":"Elife"},{"key":"5286_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12936-019-2934-4","volume":"18","author":"AR Tirrell","year":"2019","unstructured":"Tirrell AR, Vendrely KM, Checkley LA, Davis SZ, McDew-White M, Cheeseman IH, et al. Pairwise growth competitions identify relative fitness relationships among artemisinin resistant Plasmodium falciparum field isolates. Malar J. 2019;18:295.","journal-title":"Malar J"},{"key":"5286_CR15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.actatropica.2005.04.007","volume":"94","author":"HA Babiker","year":"2005","unstructured":"Babiker HA, Satti G, Ferguson H, Bayoumi R, Walliker D. Drug resistant Plasmodium falciparum in an area of seasonal transmission. Acta Trop. 2005;94:260\u20138.","journal-title":"Acta Trop"},{"key":"5286_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003578","volume":"9","author":"S Huijben","year":"2013","unstructured":"Huijben S, Bell AS, Sim DG, Tomasello D, Mideo N, Day T, et al. Aggressive chemotherapy and the selection of drug resistant pathogens. PLoS Pathog. 2013;9: e1003578.","journal-title":"PLoS Pathog"},{"key":"5286_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/eva.12530","volume":"11","author":"S Huijben","year":"2017","unstructured":"Huijben S, Paaijmans KP. Putting evolution in elimination: winning our ongoing battle with evolving malaria mosquitoes and parasites. Evol Appl. 2017;11:415\u201330.","journal-title":"Evol Appl"},{"key":"5286_CR18","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/s41467-017-01968-5","volume":"8","author":"J Zhang","year":"2017","unstructured":"Zhang J, Cunningham JJ, Brown JS, Gatenby RA. Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer. Nat Commun. 2017;8:1816.","journal-title":"Nat Commun"},{"key":"5286_CR19","first-page":"802","volume":"34","author":"RE Beardmore","year":"2017","unstructured":"Beardmore RE, Pe\u00f1a-Miller R, Gori F, Iredell J. Antibiotic cycling and antibiotic mixing: which one best mitigates antibiotic resistance? Mol Biol Evol. 2017;34:802\u201317.","journal-title":"Mol Biol Evol"},{"key":"5286_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/jac\/dkh482","volume":"55","author":"EM Brown","year":"2005","unstructured":"Brown EM, Nathwani D. Antibiotic cycling or rotation: a systematic review of the evidence of efficacy. J Antimicrob Chemother. 2005;55:6\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"5286_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1369-5274(99)00005-3","volume":"2","author":"DI Andersson","year":"1999","unstructured":"Andersson DI, Levin BR. The biological cost of antibiotic resistance. Curr Opin Microbiol. 1999;2:489\u201393.","journal-title":"Curr Opin Microbiol"},{"key":"5286_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/eva.12196","volume":"8","author":"AH Melnyk","year":"2015","unstructured":"Melnyk AH, Wong A, Kassen R. The fitness costs of antibiotic resistance mutations. Evol Appl. 2015;8:273\u201383.","journal-title":"Evol Appl"},{"key":"5286_CR23","doi-asserted-by":"publisher","first-page":"e01605","DOI":"10.1128\/JVI.01605-20","volume":"94","author":"D Lemos","year":"2020","unstructured":"Lemos D, Stuart JB, Louie W, Singapuri A, Ram\u00edrez AL, Watanabe J, et al. Two sides of a coin: a Zika virus mutation selected in pregnant rhesus macaques promotes fetal infection in mice but at a cost of reduced fitness in nonpregnant macaques and diminished transmissibility by vectors. J Virol. 2020;94:e01605-e1620.","journal-title":"J Virol"},{"key":"5286_CR24","first-page":"367","volume":"22","author":"A Chesnokov","year":"2020","unstructured":"Chesnokov A, Patel MC, Mishin VP, De La Cruz JA, Lollis L, Nguyen HT, et al. Replicative fitness of seasonal influenza A viruses with decreased susceptibility to baloxavir. J Infect Dis. 2020;22:367\u201371.","journal-title":"J Infect Dis"},{"key":"5286_CR25","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1128\/JVI.02712-06","volume":"81","author":"M Cong","year":"2007","unstructured":"Cong M, Heneine W, Garc\u00eda-Lerma JG. The fitness cost of mutations associated with Human Immunodeficiency Virus type 1 drug resistance is modulated by mutational interactions. J Virol. 2007;81:3037\u201341.","journal-title":"J Virol"},{"key":"5286_CR26","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1091\/mbc.e07-04-0379","volume":"18","author":"C Ma","year":"2007","unstructured":"Ma C, Li C, Ganesan L, Oak J, Tsai S, Sept D, et al. Mutations in \u03b1-tubulin confer dinitroaniline resistance at a cost to microtubule function. Mol Biol Cell. 2007;18:4711\u201320.","journal-title":"Mol Biol Cell"},{"key":"5286_CR27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3390\/plants8110469","volume":"8","author":"MM Vila-Aiub","year":"2019","unstructured":"Vila-Aiub MM. Fitness of herbicide-resistant weeds: current knowledge and implications for management. Plants. 2019;8:469.","journal-title":"Plants"},{"key":"5286_CR28","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1002\/ps.6306","volume":"77","author":"JC Freeman","year":"2021","unstructured":"Freeman JC, Smith LB, Silva JJ, Fan Y, Sun H, Scott JG. Fitness studies of insecticide resistant strains: lessons learned and future directions. Pest Manag Sci. 2021;77:3847\u201356.","journal-title":"Pest Manag Sci"},{"key":"5286_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41437-020-0304-1","volume":"124","author":"M Tchouakui","year":"2020","unstructured":"Tchouakui M, Riveron Miranda J, Mugenzi LMJ, Djonabaye D, Wondji MJ, Tchoupo M, et al. Cytochrome P450 metabolic resistance (CYP6P9a) to pyrethroids imposes a fitness cost in the major African malaria vector Anopheles funestus. Heredity. 2020;124:621\u201332.","journal-title":"Heredity"},{"key":"5286_CR30","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1158\/0008-5472.CAN-08-3658","volume":"69","author":"RA Gatenby","year":"2009","unstructured":"Gatenby RA, Silva AS, Gillies RJ, Frieden BR. Adaptive therapy. Cancer Res. 2009;69:4894\u2013903.","journal-title":"Cancer Res"},{"key":"5286_CR31","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s11684-018-0647-7","volume":"12","author":"L Wang","year":"2018","unstructured":"Wang L, Bernards R. Taking advantage of drug resistance, a new approach in the war on cancer. Front Med. 2018;12:490\u20135.","journal-title":"Front Med"},{"key":"5286_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006895","volume":"14","author":"D K\u00fchnert","year":"2018","unstructured":"K\u00fchnert D, Kouyos R, Shirreff G, Pe\u010derska J, Scherrer AU, B\u00f6ni J, et al. Quantifying the fitness cost of HIV-1 drug resistance mutations through phylodynamics. PLoS Pathog. 2018;14: e1006895.","journal-title":"PLoS Pathog"},{"key":"5286_CR33","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/ps.5633","volume":"76","author":"A Taquet","year":"2020","unstructured":"Taquet A, Delatte H, Barr\u00e8s B, Simiand C, Grondin M, Jourdan-Pineau H. Insecticide resistance and fitness cost in Bemisia tabaci (Hemiptera: Aleyrodidae) invasive and resident species in La R\u00e9union Island. Pest Manag Sci. 2020;76:1235\u201344.","journal-title":"Pest Manag Sci"},{"key":"5286_CR34","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3109\/1040841X.2012.716818","volume":"39","author":"M Vanaerschot","year":"2013","unstructured":"Vanaerschot M, Decuypere S, Berg M, Roy S, Dujardin JC. Drug-resistant microorganisms with a higher fitness\u2014can medicines boost pathogens? Crit Rev Microbiol. 2013;39:384\u201394.","journal-title":"Crit Rev Microbiol"},{"key":"5286_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.actatropica.2005.04.005","volume":"94","author":"D Walliker","year":"2005","unstructured":"Walliker D, Hunt P, Babiker H. Fitness of drug-resistant malaria parasites. Acta Trop. 2005;94:251\u20139.","journal-title":"Acta Trop"},{"key":"5286_CR36","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/mmi.12349","volume":"89","author":"PJ Rosenthal","year":"2013","unstructured":"Rosenthal PJ. The interplay between drug resistance and fitness in malaria parasites. Mol Microbiol. 2013;89:1025\u201338.","journal-title":"Mol Microbiol"},{"key":"5286_CR37","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrg3922","volume":"16","author":"D Hughes","year":"2015","unstructured":"Hughes D, Andersson DI. Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms. Nat Rev Genet. 2015;16:459\u201371.","journal-title":"Nat Rev Genet"},{"key":"5286_CR38","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1128\/JVI.01970-08","volume":"83","author":"CL Boutwell","year":"2009","unstructured":"Boutwell CL, Rowley CF, Essex M. Reduced viral replication capacity of Human Immunodeficiency Virus type 1 subtype C caused by cytotoxic-T-lymphocyte escape mutations in HLA-B57 epitopes of capsid protein. J Virol. 2009;83:2460\u20138.","journal-title":"J Virol"},{"key":"5286_CR39","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1128\/AAC.48.6.2295-2297.2004","volume":"48","author":"M Ender","year":"2004","unstructured":"Ender M, McCallum N, Adhikari R, Berger-B\u00e4chi B. Fitness cost of SCCmec and methicillin resistance levels in Staphylococcus aureus. Antimicrob Agents Chemother. 2004;48:2295\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"5286_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fcimb.2012.00021","volume":"2","author":"J Han","year":"2012","unstructured":"Han J, Wang Y, Sahin O, Shen Z, Guo B, Shen J, et al. A fluoroquinolone resistance associated mutation in gyrA affects DNA supercoiling in Campylobacter jejuni. Front Cell Infect Microbiol. 2012;2:21.","journal-title":"Front Cell Infect Microbiol"},{"key":"5286_CR41","doi-asserted-by":"publisher","first-page":"7866","DOI":"10.1128\/AAC.01594-15","volume":"59","author":"I Valsecchi","year":"2015","unstructured":"Valsecchi I, Mellado E, Beau R, Raj S, Latg\u00e9 JP. Fitness studies of azole-resistant strains of Aspergillus fumigatus. Antimicrob Agents Chemother. 2015;59:7866\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"5286_CR42","first-page":"433","volume":"34","author":"J Zschaler","year":"2014","unstructured":"Zschaler J, Schlorke D, Arnhold J. Differences in innate immune response between man and mouse. Crit Rev Immunol. 2014;34:433\u201354.","journal-title":"Crit Rev Immunol"},{"key":"5286_CR43","first-page":"3","volume-title":"Malaria: methods and protocols","author":"AG Maier","year":"2013","unstructured":"Maier AG, Rug M. In vitro culturing Plasmodium falciparum erythrocytic stages. In: M\u00e9nard R, editor. Malaria: methods and protocols. Totowa: Humana Press; 2013. p. 3\u201315."},{"key":"5286_CR44","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00281-012-0345-5","volume":"34","author":"P Sinnis","year":"2012","unstructured":"Sinnis P, Zavala F. The skin: where malaria infection and the host immune response begin. Semin Immunopathol. 2012;34:787\u201392.","journal-title":"Semin Immunopathol"},{"key":"5286_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.574047","volume":"8","author":"SP Harrison","year":"2021","unstructured":"Harrison SP, Baumgarten SF, Verma R, Lunov O, Dejneka A, Sullivan GJ. Liver organoids: recent developments, limitations and potential. Front Med. 2021;8: 574047.","journal-title":"Front Med"},{"key":"5286_CR46","doi-asserted-by":"publisher","first-page":"e00605","DOI":"10.1128\/AAC.00605-18","volume":"62","author":"S Nair","year":"2018","unstructured":"Nair S, Li X, Arya GA, McDew-White M, Ferrari M, Nosten F, et al. Fitness costs and the rapid spread of kelch13-C580Y substitutions conferring artemisinin resistance. Antimicrob Agents Chemother. 2018;62:e00605-e618.","journal-title":"Antimicrob Agents Chemother"},{"key":"5286_CR47","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12936-020-03157-0","volume":"19","author":"B Balikagala","year":"2020","unstructured":"Balikagala B, Sakurai-Yatsushiro M, Tachibana SI, Ikeda M, Yamauchi M, Katuro OT, et al. Recovery and stable persistence of chloroquine sensitivity in Plasmodium falciparum parasites after its discontinued use in Northern Uganda. Malar J. 2020;19:76.","journal-title":"Malar J"},{"key":"5286_CR48","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.drup.2004.08.003","volume":"7","author":"MK Laufer","year":"2004","unstructured":"Laufer MK, Plowe CV. Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies. Drug Resist Update. 2004;7:279\u201388.","journal-title":"Drug Resist Update"},{"key":"5286_CR49","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.pt.2012.08.002","volume":"28","author":"A Ecker","year":"2012","unstructured":"Ecker A, Lehane AM, Clain J, Fidock DA. Pfcrt and its role in antimalarial drug resistance. Trends Parasitol. 2012;28:504\u201314.","journal-title":"Trends Parasitol"},{"key":"5286_CR50","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12936-021-03823-x","volume":"20","author":"M Duvalsaint","year":"2021","unstructured":"Duvalsaint M, Conrad MD, Tukwasibwe S, Tumwebaze PK, Legac J, Cooper RA, et al. Balanced impacts of fitness and drug pressure on the evolution of pfmdr1 polymorphisms in Plasmodium falciparum. Malar J. 2021;20:292.","journal-title":"Malar J"},{"key":"5286_CR51","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1038\/s41467-020-17781-6","volume":"11","author":"SH Shafik","year":"2020","unstructured":"Shafik SH, Cobbold SA, Barkat K, Richards SN, Lancaster NS, Llin\u00e1s M, et al. The natural function of the malaria parasite\u2019s chloroquine resistance transporter. Nat Commun. 2020;11:3922.","journal-title":"Nat Commun"},{"key":"5286_CR52","doi-asserted-by":"publisher","first-page":"20153038","DOI":"10.1098\/rspb.2015.3038","volume":"283","author":"M Bushman","year":"2016","unstructured":"Bushman M, Morton L, Duah N, Quashie N, Abuaku B, Koram KA, et al. Within-host competition and drug resistance in the human malaria parasite Plasmodium falciparum. Proc R Soc B Biol Sci. 2016;283:20153038.","journal-title":"Proc R Soc B Biol Sci"},{"key":"5286_CR53","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.meegid.2006.03.008","volume":"7","author":"ME Osman","year":"2007","unstructured":"Osman ME, Mockenhaupt FP, Bienzle U, Elbashir MI, Giha HA. Field-based evidence for linkage of mutations associated with chloroquine (pfcrt\/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr\/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum. Infect Genet Evol. 2007;7:52\u20139.","journal-title":"Infect Genet Evol"},{"key":"5286_CR54","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1128\/AAC.48.10.3940-3943.2004","volume":"48","author":"RL Hallett","year":"2004","unstructured":"Hallett RL, Sutherland CJ, Alexander N, Ord R, Jawara M, Drakeley CJ, et al. Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes. Antimicrob Agents Chemother. 2004;48:3940\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"5286_CR55","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1475-2875-4-42","volume":"4","author":"FP Mockenhaupt","year":"2005","unstructured":"Mockenhaupt FP, Bousema JT, Eggelte TA, Ehrhardt S, Otchwemah RN, Sauerwein RW, et al. Concurrence of Plasmodium falciparum dhfr and crt mutations in northern Ghana. Malar J. 2005;4:42.","journal-title":"Malar J"},{"key":"5286_CR56","first-page":"483","volume":"73","author":"DQ Liu","year":"1995","unstructured":"Liu DQ, Liu RJ, Ren DX, Gao DQ, Zhang CY, Qui CP, et al. Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China. Bull World Health Organ. 1995;73:483\u20136.","journal-title":"Bull World Health Organ"},{"key":"5286_CR57","doi-asserted-by":"publisher","first-page":"410","DOI":"10.4269\/ajtmh.2005.72.410","volume":"72","author":"X Wang","year":"2005","unstructured":"Wang X, Mu J, Li G, Chen P, Guo X, Fu L, et al. Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People\u2019s Republic of China. Am J Trop Med Hyg. 2005;72:410\u20134.","journal-title":"Am J Trop Med Hyg"},{"key":"5286_CR58","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1086\/375419","volume":"187","author":"JG Kublin","year":"2003","unstructured":"Kublin JG, Cortese JF, Njunju EM, Mukadam RAG, Wirima JJ, Kazembe PN, et al. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis. 2003;187:1870\u20135.","journal-title":"J Infect Dis"},{"key":"5286_CR59","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1056\/NEJMoa062032","volume":"355","author":"MK Laufer","year":"2006","unstructured":"Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, et al. Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med. 2006;355:1959\u201366.","journal-title":"N Engl J Med"},{"key":"5286_CR60","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1186\/s12936-016-1637-3","volume":"15","author":"S Mwanza","year":"2016","unstructured":"Mwanza S, Joshi S, Nambozi M, Chileshe J, Malunga P, Kabuya JBB, et al. The return of chloroquine-susceptible Plasmodium falciparum malaria in Zambia. Malar J. 2016;15:584.","journal-title":"Malar J"},{"key":"5286_CR61","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1038\/s41598-020-60549-7","volume":"10","author":"GM Bwire","year":"2020","unstructured":"Bwire GM, Ngasala B, Mikomangwa WP, Kilonzi M, Kamuhabwa AAR. Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in southeast of Tanzania. Sci Rep. 2020;10:3500.","journal-title":"Sci Rep"},{"key":"5286_CR62","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3201\/eid2401.170864","volume":"24","author":"H Gupta","year":"2018","unstructured":"Gupta H, Macete E, Bulo H, Salvador C, Warsame M, Carvalho E, et al. Drug-resistant polymorphisms and copy numbers in Plasmodium falciparum, Mozambique, 2015. Emerg Infect Dis. 2018;24:40\u20138.","journal-title":"Emerg Infect Dis"},{"key":"5286_CR63","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1475-2875-12-35","volume":"12","author":"M Gharbi","year":"2013","unstructured":"Gharbi M, Flegg JA, Hubert V, Kendjo E, Metcalf JE, Bertaux L, et al. Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000\u20132011. Malar J. 2013;12:35.","journal-title":"Malar J"},{"key":"5286_CR64","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s13071-017-2298-y","volume":"10","author":"F Lu","year":"2017","unstructured":"Lu F, Zhang M, Culleton RL, Xu S, Tang J, Zhou H, et al. Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China. Parasit Vectors. 2017;10:355.","journal-title":"Parasit Vectors"},{"key":"5286_CR65","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jiph.2022.03.015","volume":"15","author":"BJ Njiro","year":"2022","unstructured":"Njiro BJ, Mutagonda RF, Chamani AT, Mwakyandile T, Sabas D, Bwire GM. Molecular surveillance of chloroquine-resistant Plasmodium falciparum in sub-Saharan African countries after withdrawal of chloroquine for treatment of uncomplicated malaria: a systematic review. J Infect Public Health. 2022;15:550\u20137.","journal-title":"J Infect Public Health"},{"key":"5286_CR66","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12936-019-2716-z","volume":"18","author":"M Ocan","year":"2019","unstructured":"Ocan M, Akena D, Nsobya S, Kamya MR, Senono R, Kinengyere AA, et al. Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors. Malar J. 2019;18:76.","journal-title":"Malar J"},{"key":"5286_CR67","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/20477724.2022.2056674","volume":"116","author":"MN Moyeh","year":"2022","unstructured":"Moyeh MN, Fankem SN, Ali IM, Sofeu D, Sandie SM, Njimoh DL, et al. Current status of 4-aminoquinoline resistance markers 18 years after cessation of chloroquine use for the treatment of uncomplicated falciparum malaria in the littoral coastline region of Cameroon. Pathog Glob Health. 2022;116:509\u201314.","journal-title":"Pathog Glob Health"},{"key":"5286_CR68","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1186\/s12936-021-03985-8","volume":"20","author":"KK Asare","year":"2021","unstructured":"Asare KK, Africa J, Mbata J, Opoku YK. The emergence of chloroquine-sensitive Plasmodium falciparum is influenced by selected communities in some parts of the Central Region of Ghana. Malar J. 2021;20:447.","journal-title":"Malar J"},{"key":"5286_CR69","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1086\/522154","volume":"196","author":"R Ord","year":"2007","unstructured":"Ord R, Alexander N, Dunyo S, Hallett R, Jawara M, Targett G, et al. Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites. J Infect Dis. 2007;196:1613\u20139.","journal-title":"J Infect Dis"},{"key":"5286_CR70","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/1475-2875-13-372","volume":"13","author":"J Inoue","year":"2014","unstructured":"Inoue J, Lopes D, do Ros\u00e1rio V, Machado M, Hristov AD, Lima GF, et al. Analysis of polymorphisms in Plasmodium falciparum genes related to drug resistance: a survey over four decades under different treatment policies in Brazil. Malar J. 2014;13:372.","journal-title":"Malar J"},{"key":"5286_CR71","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4269\/ajtmh.20-0148","volume":"104","author":"LM Montenegro","year":"2021","unstructured":"Montenegro LM, Salas de las B, Neal AT, Tobon-Casta\u00f1o A, Fairhurst RM, Lopera-Mesa TM. State of artemisinin and partner drug susceptibility in Plasmodium falciparum clinical isolates from Colombia. Am J Trop Med Hyg. 2021;104:263\u201370.","journal-title":"Am J Trop Med Hyg"},{"key":"5286_CR72","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/1475-2875-9-374","volume":"9","author":"JM Sa","year":"2010","unstructured":"Sa JM, Twu O. Protecting the malaria drug arsenal: halting the rise and spread of amodiaquine resistance by monitoring the pfcrt SVMNT type. Malar J. 2010;9:374.","journal-title":"Malar J"},{"key":"5286_CR73","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/mmi.13035","volume":"97","author":"I Petersen","year":"2015","unstructured":"Petersen I, Gabryszewski SJ, Johnston GL, Dhingra SK, Ecker A, Lewis RE, et al. Balancing drug resistance and growth rates via compensatory mutations in the Plasmodium falciparum chloroquine resistance transporter. Mol Microbiol. 2015;97:381\u201395.","journal-title":"Mol Microbiol"},{"key":"5286_CR74","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/1475-2875-13-246","volume":"13","author":"KK Asare","year":"2014","unstructured":"Asare KK, Boampong JN, Afoakwah R, Ameyaw EO, Sehgal R, Quashie NB. Use of proscribed chloroquine is associated with an increased risk of pfcrt T76 mutation in some parts of Ghana. Malar J. 2014;13:246.","journal-title":"Malar J"},{"key":"5286_CR75","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12936-020-03192-x","volume":"19","author":"DM Yobi","year":"2020","unstructured":"Yobi DM, Kayiba NK, Mvumbi DM, Boreux R, Kabututu PZ, Situakibanza HNT, et al. Molecular surveillance of anti-malarial drug resistance in Democratic Republic of Congo: high variability of chloroquinoresistance and lack of amodiaquinoresistance. Malar J. 2020;19:121.","journal-title":"Malar J"},{"key":"5286_CR76","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1128\/AAC.00711-07","volume":"52","author":"N Chen","year":"2008","unstructured":"Chen N, Gao Q, Wang S, Wang G, Gatton M, Cheng Q. No genetic bottleneck in Plasmodium falciparum wild-type pfcrt alleles reemerging in Hainan Island, China, following high-level chloroquine resistance. Antimicrob Agents Chemother. 2008;52:345\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"5286_CR77","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.actatropica.2009.12.008","volume":"114","author":"I Danquah","year":"2010","unstructured":"Danquah I, Coulibaly B, Meissner P, Petruschke I, M\u00fcller O, Mockenhaupt FP. Selection of pfmdr1 and pfcrt alleles in amodiaquine treatment failure in north-western Burkina Faso. Acta Trop. 2010;114:63\u20136.","journal-title":"Acta Trop"},{"key":"5286_CR78","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1128\/AAC.00638-09","volume":"53","author":"L Mwai","year":"2009","unstructured":"Mwai L, Kiara SM, Abdirahman A, Pole L, Rippert A, Diriye A, et al. In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. Antimicrob Agents Chemother. 2009;53:5069\u201373.","journal-title":"Antimicrob Agents Chemother"},{"key":"5286_CR79","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.3390\/ijms22116057","volume":"22","author":"H Maiga","year":"2021","unstructured":"Maiga H, Grivoyannis A, Sagara I, Traore K, Traore OB, Tolo Y, et al. Selection of pfcrt K76 and pfmdr1 N86 Coding Alleles after uncomplicated malaria treatment by artemether-lumefantrine in Mali. Int J Mol Sci. 2021;22:6057.","journal-title":"Int J Mol Sci"},{"key":"5286_CR80","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1475-2875-12-103","volume":"12","author":"M Malmberg","year":"2013","unstructured":"Malmberg M, Ngasala B, Ferreira PE, Larsson E, Jovel I, Hjalmarsson A, et al. Temporal trends of molecular markers associated with artemether-lumefantrine tolerance\/resistance in Bagamoyo district, Tanzania. Malar J. 2013;12:103.","journal-title":"Malar J"},{"key":"5286_CR81","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1086\/596738","volume":"199","author":"C Sisowath","year":"2009","unstructured":"Sisowath C, Petersen I, Veiga MI, M\u00e5rtensson A, Premji Z, Bj\u00f6rkman A, et al. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa. J Infect Dis. 2009;199:750\u20137.","journal-title":"J Infect Dis"},{"key":"5286_CR82","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ijpddr.2018.05.003","volume":"8","author":"Y Bai","year":"2018","unstructured":"Bai Y, Zhang J, Geng J, Xu S, Deng S, Zeng W, et al. Longitudinal surveillance of drug resistance in Plasmodium falciparum isolates from the China\u2013Myanmar border reveals persistent circulation of multidrug resistant parasites. Int J Parasitol Drugs Drug Resist. 2018;8:320\u20138.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5286_CR83","doi-asserted-by":"publisher","first-page":"11672","DOI":"10.1073\/pnas.1507142112","volume":"112","author":"S Pelleau","year":"2015","unstructured":"Pelleau S, Moss EL, Dhingra SK, Volney B, Casteras J, Gabryszewski SJ, et al. Adaptive evolution of malaria parasites in French Guiana: reversal of chloroquine resistance by acquisition of a mutation in pfcrt. Proc Natl Acad Sci USA. 2015;112:11672\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5286_CR84","doi-asserted-by":"publisher","first-page":"e13281","DOI":"10.1371\/journal.pone.0013281","volume":"5","author":"V Andriantsoanirina","year":"2010","unstructured":"Andriantsoanirina V, Ratsimbasoa A, Bouchier C, Tichit M, Jahevitra M, Rabearimanana S, et al. Chloroquine clinical failures in P. falciparum malaria are associated with mutant pfmdr-1, Not Pfcrt in Madagascar. PLoS ONE. 2010;5:e13281.","journal-title":"PLoS ONE"},{"key":"5286_CR85","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0140-6736(78)90616-5","volume":"311","author":"VE Rosario","year":"1978","unstructured":"Rosario VE, Walliker D, Hall R, Beale GH. Persistance of drug-resistant malaria parasites. The Lancet. 1978;311:185\u20137.","journal-title":"The Lancet"},{"key":"5286_CR86","doi-asserted-by":"publisher","first-page":"e02484","DOI":"10.1128\/AAC.02484-19","volume":"64","author":"NV Simwela","year":"2020","unstructured":"Simwela NV, Hughes KR, Roberts AB, Rennie MT, Barrett MP, Waters AP. Experimentally engineered mutations in a ubiquitin hydrolase, UBP-1, modulate in vivo susceptibility to artemisinin and chloroquine in Plasmodium berghei. Antimicrob Agents Chemother. 2020;64:e02484-e2519.","journal-title":"Antimicrob Agents Chemother"},{"key":"5286_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.672691","volume":"11","author":"M Ikeda","year":"2021","unstructured":"Ikeda M, Hirai M, Tachibana SI, Mori T, Mita T. Isolation of mutants with reduced susceptibility to piperaquine from a mutator of the rodent malaria parasite Plasmodium berghei. Front Cell Infect Microbiol. 2021;11: 672691.","journal-title":"Front Cell Infect Microbiol"},{"key":"5286_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004085","volume":"10","author":"IA Lewis","year":"2014","unstructured":"Lewis IA, Wacker M, Olszewski KL, Cobbold SA, Baska KS, Tan A, et al. Metabolic QTL analysis links chloroquine resistance in Plasmodium falciparum to impaired hemoglobin catabolism. PLoS Genet. 2014;10: e1004085.","journal-title":"PLoS Genet"},{"key":"5286_CR89","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/molbev\/msw037","volume":"33","author":"SJ Gabryszewski","year":"2016","unstructured":"Gabryszewski SJ, Modchang C, Musset L, Chookajorn T, Fidock DA. Combinatorial genetic modeling of pfcrt-mediated drug resistance evolution in Plasmodium falciparum. Mol Biol Evol. 2016;33:1554\u201370.","journal-title":"Mol Biol Evol"},{"key":"5286_CR90","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1093\/infdis\/jiac365","volume":"226","author":"KJ Wicht","year":"2022","unstructured":"Wicht KJ, Small-Saunders JL, Hagenah LM, Mok S, Fidock DA. Mutant pfcrt can mediate piperaquine resistance in African Plasmodium falciparum with reduced fitness and increased susceptibility to other antimalarials. J Infect Dis. 2022;226:2021\u20139.","journal-title":"J Infect Dis"},{"key":"5286_CR91","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/j.1365-2958.2004.04470.x","volume":"55","author":"R Hayward","year":"2005","unstructured":"Hayward R, Saliba KJ, Kirk K. pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum. Mol Microbiol. 2005;55:1285\u201395.","journal-title":"Mol Microbiol"},{"key":"5286_CR92","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/s41564-023-01377-z","volume":"8","author":"A Amambua-Ngwa","year":"2023","unstructured":"Amambua-Ngwa A, Button-Simons KA, Li X, Kumar S, Brenneman KV, Ferrari M, et al. Chloroquine resistance evolution in Plasmodium falciparum is mediated by the putative amino acid transporter AAT1. Nat Microbiol. 2023;8:1213\u201326.","journal-title":"Nat Microbiol"},{"key":"5286_CR93","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.ijpara.2007.05.003","volume":"37","author":"HB Reilly","year":"2007","unstructured":"Reilly HB, Wang H, Steuter JA, Marx AM, Ferdig MT. Quantitative dissection of clone-specific growth rates in cultured malaria parasites. Int J Parasitol. 2007;37:1599.","journal-title":"Int J Parasitol"},{"key":"5286_CR94","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/1475-2875-11-180","volume":"11","author":"MA Wacker","year":"2012","unstructured":"Wacker MA, Turnbull LB, Walker LA, Mount MC, Ferdig MT. Quantification of multiple infections of Plasmodium falciparum in vitro. Malar J. 2012;11:180.","journal-title":"Malar J"},{"key":"5286_CR95","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0035-9203(96)90129-7","volume":"90","author":"AM R\u00f8nn","year":"1996","unstructured":"R\u00f8nn AM, Msangeni HA, Mhina J, Wernsdorfer WH, Bygbjerg IC. High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Trans R Soc Trop Med Hyg. 1996;90:179\u201381.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5286_CR96","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S0035-9203(00)90272-4","volume":"94","author":"P Deloron","year":"2000","unstructured":"Deloron P, Mayombo J, Le Cardinal A, Mezui-Me-Ndong J, Bruzi-Baert C, Lekoulou F, et al. Sulfadoxine-pyrimethamine for the treatment of Plasmodium falciparum malaria in Gabonese children. Trans R Soc Trop Med Hyg. 2000;94:188\u201390.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5286_CR97","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/0035-9203(90)90016-8","volume":"84","author":"L Lege-Oguntoye","year":"1990","unstructured":"Lege-Oguntoye L, Adagu SI, Werblinska B, Ogala WN, Slotboom AB. Resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine combination in semi-immune children in Zaria, northern Nigeria. Trans R Soc Trop Med Hyg. 1990;84:505\u20136.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5286_CR98","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1473-3099(02)00239-6","volume":"2","author":"C Wongsrichanalai","year":"2002","unstructured":"Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR. Epidemiology of drug-resistant malaria. Lancet Infect Dis. 2002;2:209\u201318.","journal-title":"Lancet Infect Dis"},{"key":"5286_CR99","doi-asserted-by":"publisher","first-page":"675","DOI":"10.4269\/ajtmh.1985.34.675","volume":"34","author":"TCA Espinal","year":"1985","unstructured":"Espinal TCA, Cortes CGT, Guerra P, Arias AE. Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia. Am J Trop Med Hyg. 1985;34:675\u201380.","journal-title":"Am J Trop Med Hyg"},{"key":"5286_CR100","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1086\/342946","volume":"186","author":"JF Cortese","year":"2002","unstructured":"Cortese JF, Caraballo A, Contreras CE, Plowe CV. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J Infect Dis. 2002;186:999\u20131006.","journal-title":"J Infect Dis"},{"key":"5286_CR101","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/1475-2875-13-250","volume":"13","author":"DW Juma","year":"2014","unstructured":"Juma DW, Omondi AA, Ingasia L, Opot B, Cheruiyot A, Yeda R, et al. Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012. Malar J. 2014;13:250.","journal-title":"Malar J"},{"key":"5286_CR102","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/1475-2875-9-338","volume":"9","author":"MD Spalding","year":"2010","unstructured":"Spalding MD, Eyase FL, Akala HM, Bedno SA, Prigge ST, Coldren RL, et al. Increased prevalence of the pfdhfr\/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya. Malar J. 2010;9:338.","journal-title":"Malar J"},{"key":"5286_CR103","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.actatropica.2012.10.013","volume":"125","author":"R Abdul-Ghani","year":"2013","unstructured":"Abdul-Ghani R, Farag HF, Allam AF. Sulfadoxine-pyrimethamine resistance in Plasmodium falciparum: a zoomed image at the molecular level within a geographic context. Acta Trop. 2013;125:163\u201390.","journal-title":"Acta Trop"},{"key":"5286_CR104","doi-asserted-by":"crossref","unstructured":"Basuki S, Fitriah, Risamasu PM, Kasmijati, Ariami P, Riyanto S, et al. Origins and spread of novel genetic variants of sulfadoxine\u2013pyrimethamine resistance in Plasmodium falciparum isolates in Indonesia. Malar J. 2018;17:475.","DOI":"10.1186\/s12936-018-2597-6"},{"key":"5286_CR105","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jgar.2015.02.002","volume":"3","author":"C Severini","year":"2015","unstructured":"Severini C, Menegon M. Resistance to antimalarial drugs: an endless world war against Plasmodium that we risk losing. J Glob Antimicrob Resist. 2015;3:58\u201363.","journal-title":"J Glob Antimicrob Resist"},{"key":"5286_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2021.106049","volume":"222","author":"M Yamauchi","year":"2021","unstructured":"Yamauchi M, Hirai M, Tachibana SI, Mori T, Mita T. Fitness of sulfadoxine-resistant Plasmodium berghei harboring a single mutation in dihydropteroate synthase (DHPS). Acta Trop. 2021;222: 106049.","journal-title":"Acta Trop"},{"key":"5286_CR107","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01945-21","volume":"66","author":"V Osoti","year":"2022","unstructured":"Osoti V, Akinyi M, Wamae K, Kimenyi KM, de Laurent Z, Ndwiga L, et al. Targeted amplicon deep sequencing for monitoring antimalarial resistance markers in western Kenya. Antimicrob Agents Chemother. 2022;66: e0194521.","journal-title":"Antimicrob Agents Chemother"},{"key":"5286_CR108","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/1475-2875-9-247","volume":"9","author":"S Sridaran","year":"2010","unstructured":"Sridaran S, McClintock SK, Syphard LM, Herman KM, Barnwell JW, Udhayakumar V. Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations. Malar J. 2010;9:247.","journal-title":"Malar J"},{"key":"5286_CR109","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1086\/338566","volume":"185","author":"JG Kublin","year":"2002","unstructured":"Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, et al. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis. 2002;185:380\u20138.","journal-title":"J Infect Dis"},{"key":"5286_CR110","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.actatropica.2016.09.008","volume":"164","author":"F Kateera","year":"2016","unstructured":"Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, et al. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda. Acta Trop. 2016;164:329\u201336.","journal-title":"Acta Trop"},{"key":"5286_CR111","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4269\/ajtmh.13-0647","volume":"91","author":"GW Mbogo","year":"2014","unstructured":"Mbogo GW, Nankoberanyi S, Tukwasibwe S, Baliraine FN, Nsobya SL, Conrad MD, et al. Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda. Am J Trop Med Hyg. 2014;91:54\u201361.","journal-title":"Am J Trop Med Hyg"},{"key":"5286_CR112","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1128\/AAC.49.8.3147-3152.2005","volume":"49","author":"N Khim","year":"2005","unstructured":"Khim N, Bouchier C, Ekala MT, Incardona S, Lim P, Legrand E, et al. Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia. Antimicrob Agents Chemother. 2005;49:3147\u201352.","journal-title":"Antimicrob Agents Chemother"},{"key":"5286_CR113","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.2147\/IDR.S236898","volume":"13","author":"LY Lin","year":"2020","unstructured":"Lin LY, Li J, Huang HY, Liang XY, Jiang TT, Chen JT, et al. Trends in molecular markers associated with resistance to sulfadoxine-pyrimethamine (SP) among Plasmodium falciparum isolates on Bioko Island, Equatorial Guinea: 2011\u20132017. Infect Drug Resist. 2020;13:1203\u201312.","journal-title":"Infect Drug Resist"},{"key":"5286_CR114","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.2147\/IDR.S160164","volume":"11","author":"DF Voumbo-Matoumona","year":"2018","unstructured":"Voumbo-Matoumona DF, Kouna LC, Madamet M, Maghendji-Nzondo S, Pradines B, Lekana-Douki JB. Prevalence of Plasmodium falciparum antimalarial drug resistance genes in southeastern Gabon from 2011 to 2014. Infect Drug Resist. 2018;11:1329\u201338.","journal-title":"Infect Drug Resist"},{"key":"5286_CR115","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1128\/AAC.01228-06","volume":"51","author":"AM McCollum","year":"2007","unstructured":"McCollum AM, Mueller K, Villegas L, Udhayakumar V, Escalante AA. Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America. Antimicrob Agents Chemother. 2007;51:2085\u201391.","journal-title":"Antimicrob Agents Chemother"},{"key":"5286_CR116","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3347\/kjp.2022.60.2.109","volume":"60","author":"J Kuesap","year":"2022","unstructured":"Kuesap J, Suphakhonchuwong N, Kalawong L, Khumchum N. Molecular markers for sulfadoxine\/pyrimethamine and chloroquine resistance in Plasmodium falciparum in Thailand. Korean J Parasitol. 2022;60:109\u201316.","journal-title":"Korean J Parasitol"},{"key":"5286_CR117","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12936-020-03176-x","volume":"19","author":"R Sugaram","year":"2020","unstructured":"Sugaram R, Suwannasin K, Kunasol C, Mathema VB, Day NPJ, Sudathip P, et al. Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016. Malar J. 2020;19:107.","journal-title":"Malar J"},{"key":"5286_CR118","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/infdis\/jiv078","volume":"212","author":"E Artimovich","year":"2015","unstructured":"Artimovich E, Schneider K, Taylor TE, Kublin JG, Dzinjalamala FK, Escalante AA, et al. Persistence of sulfadoxine-pyrimethamine resistance despite reduction of drug pressure in Malawi. J Infect Dis. 2015;212:694\u2013701.","journal-title":"J Infect Dis"},{"key":"5286_CR119","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12936-020-03454-8","volume":"19","author":"MA Pacheco","year":"2020","unstructured":"Pacheco MA, Schneider KA, Cheng Q, Munde EO, Ndege C, Onyango C, et al. Changes in the frequencies of Plasmodium falciparum dhps and dhfr drug-resistant mutations in children from Western Kenya from 2005 to 2018: the rise of Pfdhps S436H. Malar J. 2020;19:378.","journal-title":"Malar J"},{"key":"5286_CR120","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1475-2875-11-134","volume":"11","author":"NC Iriemenam","year":"2012","unstructured":"Iriemenam NC, Shah M, Gatei W, van Eijk AM, Ayisi J, Kariuki S, et al. Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya. Malar J. 2012;11:134.","journal-title":"Malar J"},{"key":"5286_CR121","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126943","volume":"10","author":"SK Tessema","year":"2015","unstructured":"Tessema SK, Kassa M, Kebede A, Mohammed H, Leta GT, Woyessa A, et al. Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of sulfadoxine-pyrimethamine in North Western Ethiopia. PLoS ONE. 2015;10: e0126943.","journal-title":"PLoS ONE"},{"key":"5286_CR122","doi-asserted-by":"publisher","first-page":"256","DOI":"10.4269\/ajtmh.2008.78.256","volume":"78","author":"J Raman","year":"2008","unstructured":"Raman J, Sharp B, Kleinschmidt I, Roper C, Streat E, Kelly V, et al. Differential effect of regional drug pressure on dihydrofolate reductase and dihydropteroate synthetase mutations in southern Mozambique. Am J Trop Med Hyg. 2008;78:256\u201361.","journal-title":"Am J Trop Med Hyg"},{"key":"5286_CR123","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1128\/AAC.00975-07","volume":"52","author":"Z Zhou","year":"2008","unstructured":"Zhou Z, Griffing SM, de Oliveira AM, McCollum AM, Quezada WM, Arrospide N, et al. Decline in sulfadoxine-pyrimethamine-resistant alleles after change in drug policy in the Amazon region of Peru. Antimicrob Agents Chemother. 2008;52:739\u201341.","journal-title":"Antimicrob Agents Chemother"},{"key":"5286_CR124","unstructured":"WHO.WHO guidelines for malaria. Geneva, World Health Organization, 2024. Available from: https:\/\/www.who.int\/publications\/i\/item\/guidelines-for-malaria."},{"key":"5286_CR125","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/nyas.12661","volume":"1342","author":"CS Hopp","year":"2015","unstructured":"Hopp CS, Sinnis P. The innate and adaptive response to mosquito saliva and Plasmodium sporozoites in the skin. Ann N Y Acad Sci. 2015;1342:37\u201343.","journal-title":"Ann N Y Acad Sci"},{"key":"5286_CR126","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4269\/ajtmh.1999.61.125","volume":"61","author":"T Jelinek","year":"1999","unstructured":"Jelinek T, Kilian AH, Curtis J, Duraisingh MT, Kabagambe G, von Sonnenburg F, et al. Plasmodium falciparum: selection of serine 108 of dihydrofolate reductase during treatment of uncomplicated malaria with co-trimoxazole in Ugandan children. Am J Trop Med Hyg. 1999;61:125\u201330.","journal-title":"Am J Trop Med Hyg"},{"key":"5286_CR127","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1016\/S2352-3018(15)00005-3","volume":"2","author":"AB Suthar","year":"2015","unstructured":"Suthar AB, Vitoria MA, Nagata JM, Anglaret X, Mbori-Ngacha D, Sued O, et al. Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis. Lancet HIV. 2015;2:e137\u201350.","journal-title":"Lancet HIV"},{"key":"5286_CR128","first-page":"293","volume":"221","author":"S Huijben","year":"2020","unstructured":"Huijben S, Macete E, Mombo-Ngoma G, Ramharter M, Kariuki S, Desai M, et al. Counter-selection of antimalarial resistance polymorphisms by intermittent preventive treatment in pregnancy. J Infect Dis. 2020;221:293\u2013303.","journal-title":"J Infect Dis"},{"key":"5286_CR129","doi-asserted-by":"publisher","first-page":"320","DOI":"10.4269\/ajtmh.2008.79.320","volume":"79","author":"MJ Hamel","year":"2008","unstructured":"Hamel MJ, Greene C, Chiller T, Ouma P, Polyak C, Otieno K, et al. Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults? Am J Trop Med Hyg. 2008;79:320\u201330.","journal-title":"Am J Trop Med Hyg"},{"key":"5286_CR130","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1086\/498249","volume":"192","author":"MA Thera","year":"2005","unstructured":"Thera MA, Sehdev PS, Coulibaly D, Traore K, Garba MN, Cissoko Y, et al. Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease. J Infect Dis. 2005;192:1823\u20139.","journal-title":"J Infect Dis"},{"key":"5286_CR131","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1017\/S0031182003003020","volume":"126","author":"AA Abdel-Muhsin","year":"2003","unstructured":"Abdel-Muhsin AA, Mackinnon MJ, Awadalla P, Ali E, Suleiman S, Ahmed S, et al. Local differentiation in Plasmodium falciparum drug resistance genes in Sudan. Parasitology. 2003;126:391\u2013400.","journal-title":"Parasitology"},{"key":"5286_CR132","doi-asserted-by":"publisher","first-page":"400","DOI":"10.4269\/ajtmh.2002.67.400","volume":"67","author":"C Contreras","year":"2002","unstructured":"Contreras C, Cortese J, Caraballo A, Plowe C. Genetics of drug-resistant Plasmodium falciparum malaria in the Venezuelan state of Bolivar. Am J Trop Med Hyg. 2002;67:400\u20135.","journal-title":"Am J Trop Med Hyg"},{"key":"5286_CR133","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1475-2875-11-39","volume":"11","author":"J Gutman","year":"2012","unstructured":"Gutman J, Kachur SP, Slutsker L, Nzila A, Mutabingwa T. Combination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancy. Malar J. 2012;11:39.","journal-title":"Malar J"},{"key":"5286_CR134","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/1475-2875-10-263","volume":"10","author":"CA Morris","year":"2011","unstructured":"Morris CA, Duparc S, Borghini-Fuhrer I, Jung D, Shin CS, Fleckenstein L. Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration. Malar J. 2011;10:263.","journal-title":"Malar J"},{"key":"5286_CR135","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/cid\/cir376","volume":"53","author":"WE Harrington","year":"2011","unstructured":"Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE. Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clin Infect Dis. 2011;53:224\u201330.","journal-title":"Clin Infect Dis"},{"key":"5286_CR136","doi-asserted-by":"publisher","first-page":"e01047","DOI":"10.1128\/AAC.01047-20","volume":"64","author":"P Nayebare","year":"2020","unstructured":"Nayebare P, Asua V, Conrad MD, Kajubi R, Kakuru A, Nankabirwa JI, et al. Associations between malaria-preventive regimens and Plasmodium falciparum drug resistance-mediating polymorphisms in Ugandan pregnant women. Antimicrob Agents Chemother. 2020;64:e01047-e1120.","journal-title":"Antimicrob Agents Chemother"},{"key":"5286_CR137","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.actatropica.2005.04.014","volume":"94","author":"KI Barnes","year":"2005","unstructured":"Barnes KI, White NJ. Population biology and antimalarial resistance: the transmission of antimalarial drug resistance in Plasmodium falciparum. Acta Trop. 2005;94:230\u201340.","journal-title":"Acta Trop"},{"key":"5286_CR138","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0035-9203(93)90431-O","volume":"87","author":"WM Watkins","year":"1993","unstructured":"Watkins WM, Mosobo M. Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Trans R Soc Trop Med Hyg. 1993;87:75\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5286_CR139","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1006\/expr.1994.1019","volume":"78","author":"CJ Shinondo","year":"1994","unstructured":"Shinondo CJ, Lanners HN, Lowrie RC, Wiser MF. Effect of pyrimethamine resistance on sporogony in a Plasmodium berghei\/Anopheles stephensi model. Exp Parasitol. 1994;78:194\u2013202.","journal-title":"Exp Parasitol"},{"key":"5286_CR140","first-page":"105","volume":"24","author":"K Chen","year":"2014","unstructured":"Chen K, Sun L, Lin Y, Fan Q, Zhao Z, Hao M, et al. Competition between Plasmodium falciparum strains in clinical infections during in vitro culture adaptation. Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis. 2014;24:105\u201310.","journal-title":"Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis"},{"key":"5286_CR141","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1086\/592506","volume":"198","author":"SL Nsobya","year":"2008","unstructured":"Nsobya SL, Kiggundu M, Joloba M, Dorsey G, Rosenthal PJ. Complexity of Plasmodium falciparum clinical samples from Uganda during short-term culture. J Infect Dis. 2008;198:1554\u20137.","journal-title":"J Infect Dis"},{"key":"5286_CR142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molbiopara.2007.03.009","volume":"154","author":"CI Sandefur","year":"2007","unstructured":"Sandefur CI, Wooden JM, Quaye IK, Sirawaraporn W, Sibley CH. Pyrimethamine-resistant dihydrofolate reductase enzymes of Plasmodium falciparum are not enzymatically compromised in vitro. Mol Biochem Parasitol. 2007;154:1\u20135.","journal-title":"Mol Biochem Parasitol"},{"key":"5286_CR143","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1073\/pnas.94.4.1124","volume":"94","author":"W Sirawaraporn","year":"1997","unstructured":"Sirawaraporn W, Sathitkul T, Sirawaraporn R, Yuthavong Y, Santi DV. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proc Natl Acad Sci USA. 1997;94:1124\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5286_CR144","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1093\/molbev\/msq160","volume":"27","author":"KM Brown","year":"2010","unstructured":"Brown KM, Costanzo MS, Xu W, Roy S, Lozovsky ER, Hartl DL. Compensatory mutations restore fitness during the evolution of dihydrofolate reductase. Mol Biol Evol. 2010;27:2682\u201390.","journal-title":"Mol Biol Evol"},{"key":"5286_CR145","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12041-011-0072-z","volume":"90","author":"MS Costanzo","year":"2011","unstructured":"Costanzo MS, Hartl DL. The evolutionary landscape of antifolate resistance in Plasmodium falciparum. J Genet. 2011;90:187\u201390.","journal-title":"J Genet"},{"key":"5286_CR146","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1093\/molbev\/msu140","volume":"31","author":"K K\u00fcmpornsin","year":"2014","unstructured":"K\u00fcmpornsin K, Modchang C, Heinberg A, Ekland EH, Jirawatcharadech P, Chobson P, et al. Origin of robustness in generating drug-resistant malaria parasites. Mol Biol Evol. 2014;31:1649\u201360.","journal-title":"Mol Biol Evol"},{"key":"5286_CR147","doi-asserted-by":"publisher","first-page":"12025","DOI":"10.1073\/pnas.0905922106","volume":"106","author":"ER Lozovsky","year":"2009","unstructured":"Lozovsky ER, Chookajorn T, Brown KM, Imwong M, Shaw PJ, Kamchonwongpaisan S, et al. Stepwise acquisition of pyrimethamine resistance in the malaria parasite. Proc Natl Acad Sci USA. 2009;106:12025\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5286_CR148","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12936-016-1090-3","volume":"15","author":"CB Ogbunugafor","year":"2016","unstructured":"Ogbunugafor CB, Hartl D. A pivot mutation impedes reverse evolution across an adaptive landscape for drug resistance in Plasmodium vivax. Malar J. 2016;15:40.","journal-title":"Malar J"},{"key":"5286_CR149","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1046\/j.1365-2958.2003.03756.x","volume":"50","author":"LM Fohl","year":"2003","unstructured":"Fohl LM, Roos DS. Fitness effects of DHFR-TS mutations associated with pyrimethamine resistance in apicomplexan parasites. Mol Microbiol. 2003;50:1319\u201327.","journal-title":"Mol Microbiol"},{"key":"5286_CR150","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1038\/s41467-018-06221-1","volume":"9","author":"JL Bridgford","year":"2018","unstructured":"Bridgford JL, Xie SC, Cobbold SA, Pasaje CFA, Herrmann S, Yang T, et al. Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome. Nat Commun. 2018;9:3801.","journal-title":"Nat Commun"},{"key":"5286_CR151","doi-asserted-by":"crossref","unstructured":"Pasupureddy R, Atul, Seshadri S, Pande V, Dixit R, Pandey KC. Current scenario and future strategies to fight artemisinin resistance. Parasitol Res. 2019;118:29\u201342.","DOI":"10.1007\/s00436-018-6126-x"},{"key":"5286_CR152","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455\u201367.","journal-title":"N Engl J Med"},{"key":"5286_CR153","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"5286_CR154","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nature14412","volume":"520","author":"A Mbengue","year":"2015","unstructured":"Mbengue A, Bhattacharjee S, Pandharkar T, Liu H, Estiu G, Stahelin RV, et al. A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria. Nature. 2015;520:683\u20137.","journal-title":"Nature"},{"key":"5286_CR155","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1016\/S2666-5247(21)00249-4","volume":"3","author":"FM Kagoro","year":"2022","unstructured":"Kagoro FM, Barnes KI, Marsh K, Ekapirat N, Mercado CEG, Sinha I, et al. Mapping genetic markers of artemisinin resistance in Plasmodium falciparum malaria in Asia: a systematic review and spatiotemporal analysis. Lancet Microbe. 2022;3:e184\u201392.","journal-title":"Lancet Microbe"},{"key":"5286_CR156","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/infdis\/jiv752","volume":"213","author":"SM Chenet","year":"2016","unstructured":"Chenet SM, Akinyi Okoth S, Huber CS, Chandrabose J, Lucchi NW, Talundzic E, et al. Independent emergence of the Plasmodium falciparum kelch Propeller domain mutant allele C580Y in Guyana. J Infect Dis. 2016;213:1472\u20135.","journal-title":"J Infect Dis"},{"key":"5286_CR157","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijpddr.2021.06.001","volume":"16","author":"L Ndwiga","year":"2021","unstructured":"Ndwiga L, Kimenyi KM, Wamae K, Osoti V, Akinyi M, Omedo I, et al. A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa. Int J Parasitol Drugs Drug Resist. 2021;16:155\u201361.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5286_CR158","doi-asserted-by":"publisher","first-page":"e66277","DOI":"10.7554\/eLife.66277","volume":"10","author":"BH Stokes","year":"2021","unstructured":"Stokes BH, Dhingra SK, Rubiano K, Mok S, Straimer J, Gn\u00e4dig NF, et al. Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness. Elife. 2021;10:e66277.","journal-title":"Elife"},{"key":"5286_CR159","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1186\/s12879-023-08812-w","volume":"23","author":"CC Dieng","year":"2023","unstructured":"Dieng CC, Morrison V, Donu D, Cui L, Amoah L, Afrane Y, et al. Distribution of Plasmodium falciparum k13 gene polymorphisms across transmission settings in Ghana. BMC Infect Dis. 2023;23:801.","journal-title":"BMC Infect Dis"},{"key":"5286_CR160","first-page":"331","volume":"17","author":"F Lu","year":"2019","unstructured":"Lu F, He XL, Richard C, Cao J. A brief history of artemisinin: Modes of action and mechanisms of resistance. Chin J Nat Med. 2019;17:331\u20136.","journal-title":"Chin J Nat Med"},{"key":"5286_CR161","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12936-020-03278-6","volume":"19","author":"A Abamecha","year":"2020","unstructured":"Abamecha A, El-Abid H, Yilma D, Addisu W, Ibenthal A, Bayih AG, et al. Genetic diversity and genotype multiplicity of Plasmodium falciparum infection in patients with uncomplicated malaria in Chewaka district, Ethiopia. Malar J. 2020;19:203.","journal-title":"Malar J"},{"key":"5286_CR162","doi-asserted-by":"publisher","first-page":"20138","DOI":"10.1073\/pnas.1007068107","volume":"107","author":"JJ Juliano","year":"2010","unstructured":"Juliano JJ, Porter K, Mwapasa V, Sem R, Rogers WO, Ariey F, et al. Exposing malaria in-host diversity and estimating population diversity by capture-recapture using massively parallel pyrosequencing. Proc Natl Acad Sci USA. 2010;107:20138\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5286_CR163","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41598-018-36493-y","volume":"9","author":"P Sondo","year":"2019","unstructured":"Sondo P, Derra K, Lefevre T, Diallo-Nakanabo S, Tarnagda Z, Zampa O, et al. Genetically diverse Plasmodium falciparum infections, within-host competition and symptomatic malaria in humans. Sci Rep. 2019;9:127.","journal-title":"Sci Rep"},{"key":"5286_CR164","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/cid\/ciw388","volume":"63","author":"AP Phyo","year":"2016","unstructured":"Phyo AP, Ashley EA, Anderson TJC, Bozdech Z, Carrara VI, Sriprawat K, et al. Declining efficacy of artemisinin combination therapy against P. Falciparum malaria on the Thai-Myanmar border (2003\u20132013): the role of parasite genetic factors. Clin Infect Dis. 2016;63:784\u201391.","journal-title":"Clin Infect Dis"},{"key":"5286_CR165","doi-asserted-by":"publisher","first-page":"6533","DOI":"10.2147\/IDR.S383127","volume":"15","author":"S Zheng","year":"2022","unstructured":"Zheng S, Liang Y, Wang Z, Liu M, Chen Y, Ai Y, et al. Polymorphisms in the k13-propeller gene in artemisinin-resistant Plasmodium in mice. Infect Drug Resist. 2022;15:6533\u201344.","journal-title":"Infect Drug Resist"},{"key":"5286_CR166","doi-asserted-by":"publisher","first-page":"12513","DOI":"10.1073\/pnas.1813386115","volume":"115","author":"JM S\u00e1","year":"2018","unstructured":"S\u00e1 JM, Kaslow SR, Krause MA, Melendez-Muniz VA, Salzman RE, Kite WA, et al. Artemisinin resistance phenotypes and K13 inheritance in a Plasmodium falciparum cross and Aotus model. Proc Natl Acad Sci USA. 2018;115:12513\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5286_CR167","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.3766","volume":"5","author":"W Songsungthong","year":"2017","unstructured":"Songsungthong W, Kulawonganunchai S, Wilantho A, Tongsima S, Koonyosying P, Uthaipibull C, et al. The Plasmodium berghei RC strain is highly diverged and harbors putatively novel drug resistance variants. PeerJ. 2017;5: e3766.","journal-title":"PeerJ"},{"key":"5286_CR168","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/00034983.1999.11813429","volume":"93","author":"W Peters","year":"1999","unstructured":"Peters W, Robinson BL. The chemotherapy of rodent malaria. LVI. Studies on the development of resistance to natural and synthetic endoperoxides. Ann Trop Med Parasitol. 1999;93:325\u20139.","journal-title":"Ann Trop Med Parasitol"},{"key":"5286_CR169","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1042\/ETLS20170100","volume":"1","author":"CJ Sutherland","year":"2017","unstructured":"Sutherland CJ. Genetic markers of artemisinin resistance in Plasmodium spp. parasites. Emerg Top Life Sci. 2017;1:525\u201331.","journal-title":"Emerg Top Life Sci."},{"key":"5286_CR170","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1475-2875-12-118","volume":"12","author":"G Henriques","year":"2013","unstructured":"Henriques G, Martinelli A, Rodrigues L, Modrzynska K, Fawcett R, Houston DR, et al. Artemisinin resistance in rodent malaria\u2014mutation in the AP2 adaptor \u03bc-chain suggests involvement of endocytosis and membrane protein trafficking. Malar J. 2013;12:118.","journal-title":"Malar J"},{"key":"5286_CR171","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004019","volume":"10","author":"LC Pollitt","year":"2014","unstructured":"Pollitt LC, Huijben S, Sim DG, Salath\u00e9 RM, Jones MJ, Read AF. Rapid response to selection, competitive release and increased transmission potential of artesunate-selected Plasmodium chabaudi malaria parasites. PLoS Pathog. 2014;10: e1004019.","journal-title":"PLoS Pathog"},{"key":"5286_CR172","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1002\/ptr.7789","volume":"37","author":"L Wang","year":"2023","unstructured":"Wang L, Ji H, Ni S, Xu J, Zhang Y, Zhao X, et al. Antimalarial activity and sensitization of chrysosplenetin against artemisinin-resistant genotype Plasmodium berghei k173 potentially via dual-mechanism of maintaining host P-glycoprotein homeostasis mediated by NF-\u03baB p52 or PXR\/CAR signaling pathways and regulating heme\/haemozoin metabolism. Phytother Res PTR. 2023;37:2939\u201356.","journal-title":"Phytother Res PTR"},{"key":"5286_CR173","doi-asserted-by":"publisher","first-page":"e00172","DOI":"10.1128\/mBio.00172-17","volume":"8","author":"J Straimer","year":"2017","unstructured":"Straimer J, Gn\u00e4dig NF, Stokes BH, Ehrenberger M, Crane AA, Fidock DA. Plasmodium falciparum k13 mutations differentially impact ozonide susceptibility and parasite fitness in vitro. MBio. 2017;8:e00172-e217.","journal-title":"MBio"},{"key":"5286_CR174","doi-asserted-by":"publisher","first-page":"12622","DOI":"10.1038\/s41598-018-30593-5","volume":"8","author":"D Bunditvorapoom","year":"2018","unstructured":"Bunditvorapoom D, Kochakarn T, Kotanan N, Modchang C, K\u00fcmpornsin K, Loesbanluechai D, et al. Fitness loss under amino acid starvation in artemisinin-resistant Plasmodium falciparum isolates from Cambodia. Sci Rep. 2018;8:12622.","journal-title":"Sci Rep"},{"key":"5286_CR175","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1093\/jac\/dkv199","volume":"70","author":"A Hott","year":"2015","unstructured":"Hott A, Tucker MS, Casandra D, Sparks K, Kyle DE. Fitness of artemisinin-resistant Plasmodium falciparum in vitro. J Antimicrob Chemother. 2015;70:2787\u201396.","journal-title":"J Antimicrob Chemother"},{"key":"5286_CR176","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1128\/AAC.01924-13","volume":"58","author":"K Chotivanich","year":"2014","unstructured":"Chotivanich K, Tripura R, Das D, Yi P, Day NPJ, Pukrittayakamee S, et al. Laboratory detection of artemisinin-resistant Plasmodium falciparum. Antimicrob Agents Chemother. 2014;58:3157\u201361.","journal-title":"Antimicrob Agents Chemother"},{"key":"5286_CR177","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1365-2958.2007.05753.x","volume":"65","author":"P Hunt","year":"2007","unstructured":"Hunt P, Afonso A, Creasey A, Culleton R, Sidhu ABS, Logan J, et al. Gene encoding a deubiquitinating enzyme is mutated in artesunate- and chloroquine-resistant rodent malaria parasites. Mol Microbiol. 2007;65:27\u201340.","journal-title":"Mol Microbiol"},{"key":"5286_CR178","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1371\/journal.pgen.0010036","volume":"1","author":"W Li","year":"2005","unstructured":"Li W, Mo W, Shen D, Sun L, Wang J, Lu S, et al. Yeast model uncovers dual roles of mitochondria in action of artemisinin. PLoS Genet. 2005;1:e36.","journal-title":"PLoS Genet"},{"key":"5286_CR179","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1128\/AAC.46.8.2435-2441.2002","volume":"46","author":"JM Peters","year":"2002","unstructured":"Peters JM, Chen N, Gatton M, Korsinczky M, Fowler EV, Manzetti S, et al. Mutations in cytochrome b resulting in atovaquone resistance are associated with loss of fitness in Plasmodium falciparum. Antimicrob Agents Chemother. 2002;46:2435\u201341.","journal-title":"Antimicrob Agents Chemother"},{"key":"5286_CR180","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1128\/AAC.00241-08","volume":"53","author":"P Preechapornkul","year":"2009","unstructured":"Preechapornkul P, Imwong M, Chotivanich K, Pongtavornpinyo W, Dondorp AM, Day NPJ, et al. Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness. Antimicrob Agents Chemother. 2009;53:1509\u201315.","journal-title":"Antimicrob Agents Chemother"},{"key":"5286_CR181","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12936-015-0550-5","volume":"14","author":"WR Gimode","year":"2015","unstructured":"Gimode WR, Kiboi DM, Kimani FT, Wamakima HN, Burugu MW, Muregi FW. Fitness cost of resistance for lumefantrine and piperaquine-resistant Plasmodium berghei in a mouse model. Malar J. 2015;14:38.","journal-title":"Malar J"},{"key":"5286_CR182","doi-asserted-by":"publisher","DOI":"10.24072\/pcjournal.200","volume":"2","author":"M Villa","year":"2022","unstructured":"Villa M, Berthomieu A, Rivero A. Fitness costs and benefits in response to artificial artesunate selection in Plasmodium. Peer Comm J. 2022;2: e74.","journal-title":"Peer Comm J"},{"key":"5286_CR183","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.ento.43.1.519","volume":"43","author":"JC Beier","year":"1998","unstructured":"Beier JC. Malaria parasite development in mosquitoes. Annu Rev Entomol. 1998;43:519\u201343.","journal-title":"Annu Rev Entomol"},{"key":"5286_CR184","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/cmi.12604","volume":"18","author":"S Bennink","year":"2016","unstructured":"Bennink S, Kiesow MJ, Pradel G. The development of malaria parasites in the mosquito midgut. Cell Microbiol. 2016;18:905\u201318.","journal-title":"Cell Microbiol"},{"key":"5286_CR185","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1590\/0074-0276130597","volume":"109","author":"RC Smith","year":"2014","unstructured":"Smith RC, Vega-Rodr\u00edguez J, Jacobs-Lorena M. The Plasmodium bottleneck: malaria parasite losses in the mosquito vector. Mem Inst Oswaldo Cruz. 2014;109:644\u201361.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"5286_CR186","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1752-4571.2008.00066.x","volume":"2","author":"AF Read","year":"2009","unstructured":"Read AF, Huijben S. Perspective: Evolutionary biology and the avoidance of antimicrobial resistance. Evol Appl. 2009;2:40\u201351.","journal-title":"Evol Appl"},{"key":"5286_CR187","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.00852-21","volume":"9","author":"A Berry","year":"2021","unstructured":"Berry A, Menard S, Nsango SE, Abate L, Concordet D, Tchioffo Tsapi M, et al. The rare, the best: spread of antimalarial-resistant Plasmodium falciparum parasites by Anopheles mosquito vectors. Microbiol Spectr. 2021;9: e0085221.","journal-title":"Microbiol Spectr"},{"key":"5286_CR188","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02277-22","volume":"13","author":"Z Lapp","year":"2022","unstructured":"Lapp Z, Obala AA, Abel L, Rasmussen DA, Sumner KM, Freedman E, et al. Plasmodium falciparum genetic diversity in coincident human and mosquito hosts. MBio. 2022;13: e0227722.","journal-title":"MBio"},{"key":"5286_CR189","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/1475-2875-12-114","volume":"12","author":"C Mendes","year":"2013","unstructured":"Mendes C, Salgueiro P, Gonzalez V, Berzosa P, Benito A, do Ros\u00e1rio VE, et al. Genetic diversity and signatures of selection of drug resistance in Plasmodium populations from both human and mosquito hosts in continental Equatorial Guinea. Malar J. 2013;12:114.","journal-title":"Malar J"},{"key":"5286_CR190","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1126\/science.aad9279","volume":"352","author":"CD Goodman","year":"2016","unstructured":"Goodman CD, Siregar JE, Mollard V, Vega-Rodr\u00edguez J, Syafruddin D, Matsuoka H, et al. Parasites resistant to the antimalarial atovaquone fail to transmit by mosquitoes. Science. 2016;352:349\u201353.","journal-title":"Science"},{"key":"5286_CR191","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/infdis\/jiaa368","volume":"223","author":"S Mharakurwa","year":"2021","unstructured":"Mharakurwa S, Matsena-Zingoni Z, Mudare N, Matimba C, Gara TX, Makuwaza A, et al. Steep rebound of chloroquine-sensitive Plasmodium falciparum in Zimbabwe. J Infect Dis. 2021;223:306\u20139.","journal-title":"J Infect Dis"},{"key":"5286_CR192","doi-asserted-by":"publisher","first-page":"18796","DOI":"10.1073\/pnas.1116162108","volume":"108","author":"S Mharakurwa","year":"2011","unstructured":"Mharakurwa S, Kumwenda T, Mkulama MAP, Musapa M, Chishimba S, Shiff CJ, et al. Malaria antifolate resistance with contrasting Plasmodium falciparum dihydrofolate reductase (dhfr) polymorphisms in humans and Anopheles mosquitoes. Proc Natl Acad Sci USA. 2011;108:18796\u2013801.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5286_CR193","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.4269\/ajtmh.17-0351","volume":"97","author":"MD Conrad","year":"2017","unstructured":"Conrad MD, Mota D, Musiime A, Kilama M, Rek J, Kamya M, et al. Comparative Prevalence of Plasmodium falciparum resistance-associated genetic polymorphisms in parasites infecting humans and mosquitoes in Uganda. Am J Trop Med Hyg. 2017;97:1576\u201380.","journal-title":"Am J Trop Med Hyg"},{"key":"5286_CR194","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12936-022-04284-6","volume":"21","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Gimnig JE, Sergent SB, Liu Y, Abong\u2019o B, Otieno K, et al. Temporal trends in molecular markers of drug resistance in Plasmodium falciparum in human blood and profiles of corresponding resistant markers in mosquito oocysts in Asembo, western Kenya. Malar J. 2022;21:265.","journal-title":"Malar J"},{"key":"5286_CR195","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1098\/rspb.2008.1846","volume":"276","author":"BH Davis","year":"2009","unstructured":"Davis BH, Poon AFY, Whitlock MC. Compensatory mutations are repeatable and clustered within proteins. Proc R Soc B Biol Sci. 2009;276:1823\u20137.","journal-title":"Proc R Soc B Biol Sci"},{"key":"5286_CR196","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.mib.2003.09.001","volume":"6","author":"DI Andersson","year":"2003","unstructured":"Andersson DI. Persistence of antibiotic resistant bacteria. Curr Opin Microbiol. 2003;6:452\u20136.","journal-title":"Curr Opin Microbiol"},{"key":"5286_CR197","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.tim.2018.01.005","volume":"26","author":"P Dur\u00e3o","year":"2018","unstructured":"Dur\u00e3o P, Balbont\u00edn R, Gordo I. Evolutionary mechanisms shaping the maintenance of antibiotic resistance. Trends Microbiol. 2018;26:677\u201391.","journal-title":"Trends Microbiol"},{"key":"5286_CR198","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/genetics\/154.3.985","volume":"154","author":"BR Levin","year":"2000","unstructured":"Levin BR, Perrot V, Walker N. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics. 2000;154:985\u201397.","journal-title":"Genetics"},{"key":"5286_CR199","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cois.2017.04.011","volume":"21","author":"RH Ffrench-Constant","year":"2017","unstructured":"Ffrench-Constant RH, Bass C. Does resistance really carry a fitness cost? Curr Opin Insect Sci. 2017;21:39\u201346.","journal-title":"Curr Opin Insect Sci"},{"key":"5286_CR200","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1128\/jvi.70.6.3763-3769.1996","volume":"70","author":"L Doyon","year":"1996","unstructured":"Doyon L, Croteau G, Thibeault D, Poulin F, Pilote L, Lamarre D. Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors. J Virol. 1996;70:3763\u20139.","journal-title":"J Virol"},{"key":"5286_CR201","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.antiviral.2011.10.010","volume":"92","author":"E Gonz\u00e1lez-Ortega","year":"2011","unstructured":"Gonz\u00e1lez-Ortega E, Ballana E, Badia R, Clotet B, Est\u00e9 JA. Compensatory mutations rescue the virus replicative capacity of VIRIP-resistant HIV-1. Antiviral Res. 2011;92:479\u201383.","journal-title":"Antiviral Res"},{"key":"5286_CR202","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.virusres.2007.12.021","volume":"134","author":"J Martinez-Picado","year":"2008","unstructured":"Martinez-Picado J, Mart\u00ednez MA. HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo. Virus Res. 2008;134:104\u201323.","journal-title":"Virus Res"},{"key":"5286_CR203","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/mmi.12162","volume":"88","author":"A Heinberg","year":"2013","unstructured":"Heinberg A, Siu E, Stern C, Lawrence EA, Ferdig MT, Deitsch KW, et al. Direct evidence for the adaptive role of copy number variation on antifolate susceptibility in Plasmodium falciparum. Mol Microbiol. 2013;88:702\u201312.","journal-title":"Mol Microbiol"},{"key":"5286_CR204","doi-asserted-by":"publisher","first-page":"e1759","DOI":"10.1073\/pnas.1322965111","volume":"111","author":"RL Summers","year":"2014","unstructured":"Summers RL, Dave A, Dolstra TJ, Bellanca S, Marchetti RV, Nash MN, et al. Diverse mutational pathways converge on saturable chloroquine transport via the malaria parasite\u2019s chloroquine resistance transporter. Proc Natl Acad Sci USA. 2014;111:e1759\u201367.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5286_CR205","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002484","volume":"3","author":"H Jiang","year":"2008","unstructured":"Jiang H, Patel JJ, Yi M, Mu J, Ding J, Stephens R, et al. Genome-wide compensatory changes accompany drug-selected mutations in the Plasmodium falciparum crt gene. PLoS ONE. 2008;3: e2484.","journal-title":"PLoS ONE"},{"key":"5286_CR206","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.chom.2021.11.002","volume":"29","author":"P Mes\u00e9n-Ram\u00edrez","year":"2021","unstructured":"Mes\u00e9n-Ram\u00edrez P, Bergmann B, Elhabiri M, Zhu L, von Thien H, Castro-Pe\u00f1a C, et al. The parasitophorous vacuole nutrient channel is critical for drug access in malaria parasites and modulates the artemisinin resistance fitness cost. Cell Host Microbe. 2021;29:1774-1787.e9.","journal-title":"Cell Host Microbe"},{"issue":"285","key":"5286_CR207","first-page":"e1","volume":"22","author":"C Putaporntip","year":"2016","unstructured":"Putaporntip C, Kuamsab N, Kosuwin R, Tantiwattanasub W, Vejakama P, Sueblinvong T, et al. Natural selection of K13 mutants of Plasmodium falciparum in response to artemisinin combination therapies in Thailand. Clin Microbiol Infect. 2016;22(285):e1-8.","journal-title":"Clin Microbiol Infect"},{"key":"5286_CR208","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12936-018-2532-x","volume":"17","author":"KF Breglio","year":"2018","unstructured":"Breglio KF, Amato R, Eastman R, Lim P, Sa JM, Guha R, et al. A single nucleotide polymorphism in the Plasmodium falciparum atg18 gene associates with artemisinin resistance and confers enhanced parasite survival under nutrient deprivation. Malar J. 2018;17:391.","journal-title":"Malar J"},{"issue":"Suppl","key":"5286_CR209","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1017\/S0031182000075235","volume":"104","author":"KP Day","year":"1992","unstructured":"Day KP, Koella JC, Nee S, Gupta S, Read AF. Population genetics and dynamics of Plasmodium falciparum: an ecological view. Parasitology. 1992;104(Suppl):S35-52.","journal-title":"Parasitology"},{"key":"5286_CR210","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1128\/AAC.00902-06","volume":"51","author":"JJ Kwiek","year":"2007","unstructured":"Kwiek JJ, Alker AP, Wenink EC, Chaponda M, Kalilani LV, Meshnick SR. Estimating true antimalarial efficacy by heteroduplex tracking assay in patients with complex Plasmodium falciparum infections. Antimicrob Agents Chemother. 2007;51:521\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"5286_CR211","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.drup.2005.03.003","volume":"8","author":"IM Hastings","year":"2005","unstructured":"Hastings IM, Donnelly MJ. The impact of antimalarial drug resistance mutations on parasite fitness, and its implications for the evolution of resistance. Drug Resist Update. 2005;8:43\u201350.","journal-title":"Drug Resist Update"},{"key":"5286_CR212","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/cid\/ciq049","volume":"52","author":"C Men\u00e9ndez","year":"2011","unstructured":"Men\u00e9ndez C, Serra-Casas E, Scahill MD, Sanz S, Nhabomba A, Bardaj\u00ed A, et al. HIV and placental infection modulate the appearance of drug-resistant Plasmodium falciparum in pregnant women who receive intermittent preventive treatment. Clin Infect Dis. 2011;52:41\u20138.","journal-title":"Clin Infect Dis"},{"key":"5286_CR213","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01529-21","volume":"66","author":"S Nair","year":"2022","unstructured":"Nair S, Li X, Arya GA, McDew-White M, Ferrari M, Anderson T. Nutrient limitation magnifies fitness costs of antimalarial drug resistance mutations. Antimicrob Agents Chemother. 2022;66: e0152921.","journal-title":"Antimicrob Agents Chemother"},{"key":"5286_CR214","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000335","volume":"5","author":"LS Garver","year":"2009","unstructured":"Garver LS, Dong Y, Dimopoulos G. Caspar controls resistance to Plasmodium falciparum in diverse anopheline species. PLoS Pathog. 2009;5: e1000335.","journal-title":"PLoS Pathog"},{"key":"5286_CR215","doi-asserted-by":"publisher","first-page":"12566","DOI":"10.1073\/pnas.1716181114","volume":"114","author":"FM Gomes","year":"2017","unstructured":"Gomes FM, Hixson BL, Tyner MDW, Ramirez JL, Canepa GE, AlveseSilva TL, et al. Effect of naturally occurring Wolbachia in Anopheles gambiae s.l. mosquitoes from Mali on Plasmodium falciparum malaria transmission. Proc Natl Acad Sci USA. 2017;114:12566\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5286_CR216","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1146\/annurev-genet-120215-035211","volume":"50","author":"A Molina-Cruz","year":"2016","unstructured":"Molina-Cruz A, Zilversmit MM, Neafsey DE, Hartl DL, Barillas-Mury C. Mosquito vectors and the globalization of Plasmodium falciparum Malaria. Annu Rev Genet. 2016;50:447\u201365.","journal-title":"Annu Rev Genet"},{"key":"5286_CR217","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41579-019-0306-2","volume":"18","author":"K Venugopal","year":"2020","unstructured":"Venugopal K, Hentzschel F, Valki\u016bnas G, Marti M. Plasmodium asexual growth and sexual development in the haematopoietic niche of the host. Nat Rev Microbiol. 2020;18:177\u201389.","journal-title":"Nat Rev Microbiol"},{"key":"5286_CR218","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S1016-8478(23)13720-4","volume":"15","author":"REL Paul","year":"2003","unstructured":"Paul REL, Brey PT. Malaria parasites and red blood cells: from anaemia to transmission. Mol Cells. 2003;15:139\u201349.","journal-title":"Mol Cells"},{"key":"5286_CR219","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025478","volume":"7","author":"F Frischknecht","year":"2017","unstructured":"Frischknecht F, Matuschewski K. Plasmodium sporozoite biology. Cold Spring Harb Perspect Med. 2017;7: a025478.","journal-title":"Cold Spring Harb Perspect Med"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05286-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05286-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05286-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T06:34:45Z","timestamp":1740810885000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05286-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":219,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5286"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05286-w","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"3 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}